Flexible-Dose Trial in Early Parkinson's Disease (PD)

Clinical trial NCT04223193 · COMPLETED

Trial details

NCT number: NCT04223193
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2020-01-06
Primary completion: 2024-10-01
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.